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Background: Leishmaniases are tropical zoonotic diseases, caused by parasites from the genus Leishmania. New
World (NW) species are related to sylvatic cycles although urbanization processes have been reported in some
South American Countries such as Colombia. This eco-epidemiological complexity imposes a challenge to the
detection of circulating parasite species, not only related to human cases but also infecting vectors and reservoirs.
Currently, no harmonized methods have been deployed to discriminate the NW Leishmania species.
Findings: Herein, we conducted a systematic and mechanistic High-Resolution Melting (HRM) assay targeted to
HSP70 and ITS1. Specific primers were designed that coupled with a HRM analyses permitted to discriminate six
NW Leishmania species. In order to validate the herein described algorithm, we included 35 natural isolates obtained
from human cases, insect vectors and mammals. Our genotyping assay allowed the correct assignment of the six NW
Leishmania species (L. mexicana, L. infantum (chagasi), L. amazonensis, L. panamensis, L. guyanensis and L. braziliensis)
based on reference strains. When the algorithm was applied to a set of well-characterized strains by means of
PCR-RFLP, MLEE and monoclonal antibodies (MA) we observed a tailored concordance between the HRM and
PCR-RFLP/MLEE/MA (KI = 1.0). Additionally, we tested the limit of detection for the HRM method showing that
this is able to detect at least 10 equivalent-parasites per mL.
Conclusions: This is a rapid and reliable method to conduct molecular epidemiology and host-parasite association
studies in endemic areas.
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Leishmaniasis is a tropical infection caused by the kineto-
plastid parasites of the genus Leishmania, and is naturally
transmitted to humans and among reservoirs by sandfly
bites [1]. With a worldwide distribution and a large number
of clinical cases, Leishmaniasis affects around 12 million
individuals and 350 million are at risk of contracting
the disease representing a serious issue in public health
[2]. Additionally, control strategies against the disease are a
challenge due to its eco-epidemiological complexity, involv-
ing sylvatic and domestic multi host-pathogen interactions* Correspondence: juand.ramirez@urosario.edu.co
†Equal contributors
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article, unless otherwise stated.(humans as well as a wide range of mammalian hosts).
Recently, armed conflicts, increased tourism, natural
disasters, deforestation, environmental and climate changes
have contributed with new challenges to disease prevention
and control: vectors distributions are reaching higher alti-
tudes and latitudes increasing population at risk and chan-
ging the paradigm of poverty related disease [3-5].
The Neotropical Leishmania species responsible for a
diversity of clinical symptoms are grouped in the two sub-
genera: Viannia and Leishmania. Within the Viannia
subgenus, the species Leishmania (Viannia) braziliensis,
Leishmania (Viannia) panamensis and Leishmania
(Viannia) guyanensis are the most important causal
agents of the New World tegumentary Leishmaniasis.
From the Leishmania subgenus, the species Leishmaniatral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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ceral Leishmaniasis) and the species of Leishmania
(Leishmania) amazonesis and Leishmania (Leishmania)
mexicana are responsible for the mucocutaneous, cuta-
neous and diffuse manifestations [6,7]. These parasite spe-
cies have a wide geographic distribution from Mexico to
the north of Argentina [6], with a significant increase in
the last years in the number of cases in countries such as
Bolivia, Brazil, Colombia and Peru [6,8-10]. The epidemio-
logical complexity can be accompanied by a clinical diffi-
culty when some infections, such as the one caused by L.
braziliensis, appear in a cutaneous form and after self-
healing reappear years later in a mucocutaneous form.
This kind of situations makes species identification a crit-
ical step in clinical diagnosis and management.
As in most parasitic diseases, the challenge remains in
having the ability to perform a rapid diagnosis of the
disease and the characterization and genotyping of the
different isolates obtained from infected individuals [11].
So far, the techniques typically employed to characterize
and discriminate Leishmania species are Multi Locus
Enzyme Electrophoresis (MLEE) [12] and multiple methods
based on Polymerase Chain Reaction (PCR) such
as Multilocus Sequence Typing (MLST) [13], PCR-
Restriction Fragment Length Polymorphism (PCR-RFLP)
[14], Multiplex PCR [15] and PCR followed by sequen-
cing [16]. These methods usually use microsatellites
genes as amplification targets such as: kinetoplastid DNA
(kDNA), telomeric sequences, internal transcribed spacer
(ITS1), Heat Shock Proteins such as HSP70 and HSP60,
and genes involved in metabolic processes like Mannose
Phosphate Isomerase (MPI) and 6-phosphogluconate de-
hydrogenase (6GPD) [11-13,17].
From this great variety of molecular targets, kDNA,
ITS1, and HSP70 have been the widest employed markers
due to their abundance in the number of copies across
Leishmania genome which increases the sensitivity of
the assays [18-20]. However, traditional methods have
multiple disadvantages including long procedures that
entail an increased risk of DNA contamination, interpret-
ation and processing of complex data, low sensitivity, high
cost and cross-reactivity [21]. To overcome these disad-
vantages, Real-Time PCR methods, particularly those that
use SYBR Green, TaqMan probes or FRET [11-13,17,22],
have become available in the last few years to ensure
better reproducibility, specificity, sensitivity, and velocity
during diagnosing and genotyping [23,24]. Some of these
methods can distinguish between the two subgenera L.
(Leishmania) and L (Viannia) at a complex level, but with
many cross-reactions of human DNA and other mammals
[11]. Albeit, other methods can only distinguish among
the species of the L. (Viannia) complex [13-17].
From this perspective, it is mandatory to develop and
implement a technique that allows specific, rapid, robust,and cost-effective identification of the Leishmania species
circulating in the New World to be employed in both clin-
ical and eco-epidemiological studies. High Resolution
Melting (HRM) is a technique that has been widely used
in the genotyping of bacteria, fungi, protozoan parasites
and vertebrates [25-29] and could be used for identifica-
tion and genotyping of these Leishmania species [30]. The
objective of this study was to evaluate the potential of the
HSP70 and ITS1 genes in genotyping six Leishmania spe-
cies present in the New World through the use of High
Resolution Melting (HRM).
Promastigotes of the reference strains L. panamensis
(MHOM/PA/71/LS94), L. guyanensis (MHOM/BR/75/
M4147), L. braziliensis (MHOM/BR/75/M2903), L. ama-
zonensis (IFLA/BR/67/PH8), L. mexicana (MHOM/BZ/
82/BEL21) and L. infantum (chagasi) (MHOM/TN/80/
IPT1) were kindly provided by the Centro Internacional
de Entrenamiento e Investigaciones Medicas (CIDEIM).
Parasites were maintained in a biphasic medium of Liver
Infusion (Tobie medium infused with human blood)
and Triptone (LIT) supplemented with Bovine fetal serum
inactivated at 20% and incubated at 25°C for 5 days to
reach the late logarithmic growth phase. Aliquots of
200 μL of the LIT biphasic culture medium were ob-
tained and then used for DNA extraction using the
Roche High Pure PCR Template Preparation Kit™ fol-
lowing the respective instructions of the insert. The
obtained DNA was quantified in a NanoDrop 2000 at a
wavelength of 260 nm.
HSP70 and ITS1 genes were used given their good
performance as reported by other authors [24-26]. For
the HSP70 gene, primer design was carried out using
the sequences available on GenBank, TriTrypDB and
www.itg.be/leishmaniahsp70 of New World Leishmania
spp. (L. mexicana (XM_003877072.1); L. amazonensis
(L14605.1); L. braziliensis (AF291716.1); L.guyanensis
(EU599093.1); L. infantum (chagasi) (XM_003392632.1);
L. panamensis (FN395055.1)). Multiple alignments (1380 bp)
were performed using the software Mega 5 [31]. Primers
were designed using the software PRIMER BLAST (http://
www.ncbi.nlm.nih.gov/tools/primer-blast/) from the con-
sensus sequence obtained by the multiple alignments, with
an expected amplicon size of 337 bp for all the sequences.
For the amplification of ITS1 gene, the primers reported
by El Tai et. al (2000) were used and adapted to the condi-
tions of Real-Time PCR of this study. The expected ampli-
con size in this case was 300–350 pb.
Real-Time PCR was coupled together with HRM ana-
lysis using the HSP70 and ITS1 genes as targets in a
Real-Time PCR system 7500 (Applied Biosystems, Inc.,
CA, USA) with 21 μL amplification reactions. The reac-
tion mix contained 1X of Master Mix MeltDoctor HRM
(Applied Biosystems, Inc., CA, USA), a 5 μM solution of
each primers HSP70F (5’ AGG TGA AGG CGA CGA
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GCG TC 3’) for the amplification of HSP70 and for
ITS1, LITSR (5’ CTG GAT CAT TTT CCG ATG 3’) and
L5.8S (5’ TGA TAC CAC TTA TCG CAC TT 3’) [32],
6.6 μL of water and 10 ng/μL of DNA template. Real-
Time PCR cycle conditions were adjusted to the following
protocol: 95°C for 10 minutes (1 cycle) followed by a 40-
cycles amplification (95°C for 15 seconds (denaturation)
and then 60°C for 1 minute). After the Real-Time PCR, a
dissociation of the amplicon was performed and followed
immediately by a fusion step. The thermal profile con-
sisted in denaturation at 95°C for 10 seconds, annealing at
60°C for 1 minute, High Resolution Melting at 95°C for
30 seconds, and a final annealing stage at 60°C for 15 sec-
onds. During this process, the amplicons obtained from
PCR were denatured prior to the development of meltingFigure 1 Melting Temperature profiles and scatter plots of the HRM g
each species of Leishmania for the genes HSP70 and ITS1. B. Box diagram s
curves of each species of Leishmania.curves in the inflexion point where changes in fluores-
cence with respect to changes in temperature (dF/dT)
were recorded with a ramp of 0.1°C/seg [25]. Each DNA
sample was analyzed in duplicate. Finally, the profiles of
the normalized and derived fusion curves were obtained.
Analyses of the obtained melting values were conducted
with the software Graphpad Prism 6 (GraphPah Software,
San Diego California USA, www.graphpad.com) to
determine mean and standard deviations. To verify the
reproducibility of the genotyping assay, this process
was performed on 15 different days with the same DNA
aliquots under the same conditions. The contamination
controls of the study always included two controls of
reaction mix without DNA (controls without templates -
NTC). To evaluate the cross-reactivity, uninfected human
and mouse DNA were tested and compared to the knownenotyping assay. A. Representative normalized melting curves of
howing the range of obtained temperatures of melting (Tm) for the
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Leishmania species. Serial dilutions (factor 10) from 106
to 1 parasite per mL were performed to establish the
detection limit, which was defined as the minimum
number of parasites necessary to generate a melting curve
inside the reference values.
To determine the accuracy and reliability of the method
herein reported, we analyzed 35 Leishmania strains
obtained from humans, reservoirs and insect vectors
from Colombia that were previously characterized by
PCR-RFLP, monoclonal antibodies and MLEE. The HRM
was applied in blind to this set of well-characterized
strains and examined by duplicate. Based on this
characterization, we determined the concordance
between PCR-RFLP, MLEE and the HRM algorithm by
means of the Kappa Index.
Primers for the HSP70 gene designed to obtain
specific melting temperatures were able to discrimin-
ate the subgenera L. (Leishmania) and L. (Viannia) and
the complexes L. mexicana from L. infantum (chagasi) -
L. amazonensis and L. panamensis from L. braziliensis -
L. guyanensis (Figure 1A). For the ITS1 gene, the obtained
ranges allowed clear discrimination of the species L. infantum
(chagasi) from L. amazonensis and L. braziliensis from
L. guyanensis (Figure 1B). These results were used to
construct the herein showed algorithm (Figure 2)
which, following the amplification of HSP70 and then
ITS1, can be used to discriminate six Leishmania species.Figure 2 Algorithm that shows the use of HRM assays for genes HSP7No cross-reactivity was observed during the assays for
HSP70 or ITS1 genes with uninfected human and mouse
DNA. The detection limit for the HRM assay was
determined on average in all examined species to be 10
parasites/mL for both markers. Based on the designed
algorithm, we tested 35 well-characterized Leishmania
strains. We were able to obtain reliable Tm curves for
each strain that were in accordance with the ranges
found in the reference strains (Table 1). We calculated
the Kappa Index considering PCR-RFLP/MLEE as the
gold standard and the results showed a High concordance
between HRM and PCR-RFLP/MLEE (KI = 1.0).
Currently, the methods employed for the discrimination
of New World Leishmania species are laborious, subject-
ive and often lacking of specificity [21]. Therefore, it is
crucial to count on a low-cost, effective and rapid tool that
allows an accurate detection and identification of the
Leishmania species present in the New World or at
least the most prevalent. Herein, the proposed algo-
rithm allowed identifying L. mexicana, L. infantum
(chagasi), L. amazonensis, L. panamensis, L. braziliensis
and L. guyanensis with a Real-Time PCR coupled with
HRM analysis after the amplification of HSP70 gene and
the subsequent amplification of ITS1 gene. The HRM
methodology is considered as an excellent option to reduce
some problems of the previously molecular techniques used
for Leishmania genotyping such as the need of modified
oligonucleotides, low accuracy, limited high-throughput0 and ITS1 in differentiating species of New World Leishmania.
Table 1 Comparison of HRM assay and PCR-RFLP/MLEE in the set of well-characterized Leishmania strains
Sample name Geographical origin Host PCR-RFLP/MLEE HSP70 Tm ITS1 Tm
6 Meta/Colombia Homo sapiens L. guyanensis L. guyanensis/L. braziliensis 90,08 L. guyanensis 79,22
7 Santander/Colombia Lutzomyia umbratilis L. guyanensis L. guyanensis/L. braziliensis 90,07 L. guyanensis 79,21
71 Boyaca/Colombia Lutzomyia umbratilis L. guyanensis L. guyanensis/L. braziliensis 90,07 L. guyanensis 79,23
875 Santander/Colombia Homo sapiens L. infantum (chagasi) L. guyanensis/L. braziliensis 90,07 L. chagasi 79,21
924 Santander/Colombia Homo sapiens L. panamensis L. panamensis 89,91 L. panamensis -
113 Meta/Colombia Homo sapiens L. braziliensis L. guyanensis/L. braziliensis 90,08 L. braziliensis 78,77
12 Boyaca/Colombia Homo sapiens L. braziliensis L. guyanensis/L. braziliensis 90,09 L. braziliensis 78,55
13 Boyaca/Colombia Homo sapiens L. guyanensis L. guyanensis/L. braziliensis 90,06 L. guyanensis 79,22
15 Boyaca/Colombia Didelphis marsupialis L. panamensis L. panamensis 89,73 L. panamensis -
19 Meta/Colombia Lutzomyia spinicrassa L. braziliensis L. guyanensis/L. braziliensis 90,09 L. braziliensis 78,77
20 Meta/Colombia Lutzomyia trapidoi L. panamensis L. panamensis 89,73 L. panamensis -
21 Meta/Colombia Lutzomyia trapidoi L. panamensis L. panamensis 89,83 L. panamensis -
23 Meta/Colombia Lutzomyia trapidoi L. panamensis L. panamensis 89,73 L. panamensis -
86 Santander/Colombia Homo sapiens L. infantum (chagasi) L. infantum/L. amazonensis 89,14 L. chagasi 78,33
87 Santander/Colombia Homo sapiens L. infantum (chagasi) L. infantum/L. amazonensis 89,17 L. chagasi 78,56
94 Santander/Colombia Homo sapiens L. infantum (chagasi) L. infantum/L. amazonensis 89,19 L. chagasi 78,55
094b Antioquia/Colombia Didelphis marsupialis L. mexicana L. mexicana 88,75 L. mexicana -
245 Antioquia/Colombia Homo sapiens L. amazonensis L. infantum/L. amazonensis 89,19 L. amazonensis 80,61
280 Antioquia/Colombia Homo sapiens L. amazonensis L. infantum/L. amazonensis 89,19 L. amazonensis 80,77
916 Antioquia/Colombia Lutzomyia trapidoi L. panamensis L. panamensis 89,79 L. panamensis -
916 Antioquia/Colombia Lutzomyia trapidoi L. panamensis L. panamensis 89,73 L. panamensis -
984 Antioquia/Colombia Homo sapiens L. braziliensis L. guyanensis/L. braziliensis 90,04 L. braziliensis 78,77
985 Antioquia/Colombia Lutzomyia spinicrassa L. braziliensis L. guyanensis/L. braziliensis 90,08 L. braziliensis 78,89
986 Meta/Colombia Homo sapiens L. braziliensis L. guyanensis/L. braziliensis 90,09 L. braziliensis 78,91
990 Meta/Colombia Homo sapiens L. guyanensis L. guyanensis/L. braziliensis 90,04 L. guyanensis 79,22
094b Meta/Colombia Homo sapiens L. infantum (chagasi) L. infantum/L. amazonensis 89,22 L. chagasi 78,67
094b Meta/Colombia Homo sapiens L. infantum (chagasi) L. infantum/L. amazonensis 89,29 L. chagasi 78,66
101 Boyaca/Colombia Homo sapiens L. amazonensis L. infantum/L. amazonensis 89,14 L. amazonensis 81,11
123 Boyaca/Colombia Homo sapiens L. braziliensis L. guyanensis/L. braziliensis 90,02 L. braziliensis 78,66
157 Santander/Colombia Homo sapiens L. guyanensis L. guyanensis/L. braziliensis 90,04 L. guyanensis 79,22
146 Santander/Colombia Homo sapiens L. guyanensis L. guyanensis/L. braziliensis 90,01 L. guyanensis 79,22
147 Santander/Colombia Didelphis marsupialis L. mexicana L. mexicana 88,37 L. mexicana -
222 Santander/Colombia Homo sapiens L. panamensis L. panamensis 89,82 L. panamensis -
2698 Santander/Colombia Homo sapiens L. panamensis L. panamensis 89,81 L. panamensis -
1453 Santander/Colombia Lutzomyia trapidoi L. panamensis L. panamensis 89,88 L. panamensis -
Hernández et al. Parasites & Vectors 2014, 7:501 Page 5 of 7
http://www.parasitesandvectors.com/content/7/1/501applications, etc. [33] since this is a closed-tube assay (does
not require additional precautions to prevent crossover
of PCR products), avoids sequencing processes, labori-
ous procedures and high costs as well as offering robust
and high efficiency in its results [25,34]. On average, this
type of test has been calculated to be three times faster
and five times cheaper than other types of analysis such as
MLST and RFLPs [17].
Additionally, our algorithm helps to differentiate between
L. (L). mexicana and L. (L). amazonensis, two species thatin previous studies could not be identified using HRM tests
[11,17]. This differentiation is important, and although
L. (L.) amazonensis infections usually exhibit a milder
form of the disease, it can also cause diffuse forms that do
not respond adequately to existing treatments [35]. On the
other hand, our algorithm can also differentiate between
L. braziliensis (the main etiologic cause of cutaneous
Leishmaniasis) and L. guyanensis (with high prevalence in
the Amazon region). This is of great importance due to
its eco-epidemiological implications and the close genetic
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has represented a limited number of techniques that can
be used to correctly identify them [36]. As well, HSP70
and ITS1 showed a higher resolution in characterizing the
members of the subgenera Viannia and Leishmania than
other genes. For example, markers like kDNA can only
discriminate between fewer members of these subgenera
but are nonetheless used in many assays as a gold stand-
ard for diagnosis of Old and New World Leishmaniasis
due to its high sensitivity [11,17].
The results of our study support the idea that genes
such HSP70 and ITS1 are good candidates for genotyping
neotropical Leishmania species, and that these genes
allow detection of genetic variability in molecules associ-
ated with immunological processes (HSP70) and confer a
high probability of being detected due to their high
number of copies [35]. Similarly, regarding specificity, this
method does not cause mammalian DNA cross-reactions
like has been previously noted in studies using HRM [11].
This fact makes HRM a good candidate for identifying
Leishmania in epidemiological studies. Also, the technique
is reproducible, and this was retained even though the
tests were duplicated and performed on different days,
albeit under the same conditions of DNA and reactive
concentrations.
We decided to apply this algorithm to a set of
well-characterized strains by the gold standard method
(PCR-RFLP/MLEE). The findings allowed observing that
HRM was accurate enough to discriminate six Neotropical
species and was 100% concordant with PCR-RFLP/MLEE
which suggests its suitability in the application to a broad
number of epidemiological questions. Another important
feature of our assay besides its reproducibility was a
tailored sensitivity obtained where the method is able to
detect at least 10 parasites/mL and is considered a re-
markable value of sensitivity. These advantages demon-
strate that this method has a tremendous potential for the
identification of New World Leishmania species and is a
suitable choice for identification and characterization.
Nonetheless, it is important to point out that the
Leishmania strains employed in this implementation
were isolated from Colombian hosts and unbiased range
of Leishmania diversity was not considered. Therefore,
we suggest that this novel method is implemented in
strains from Meso-America in order to validate the
feasibility of the technique.
Conclusions
In conclusion, the suggested HRM assay in this study is
a reliable, robust and reproducible technique that allows
the correct genotyping of six New World Leishmania
species, in a rapid way (it does not require post-PCR
treatments), little labor and low cost (around 7.5 USD)
with a potential applicability in different areas of molecularepidemiology of Leishmaniasis such as host-parasite
relationships, eco-epidemiology and infection dynamics in
urban and wild areas. We encourage the scientific
community from Leishmania endemic areas to test this
novel approach in order to fully validate its reliability at a
continental level.
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